Correlogic Systems (Ovarian Cancer Diagnostics Business) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Correlogic Systems (Ovarian Cancer Diagnostics Business) General Information

Description

Developer of diagnostic test for ovarian cancer. The business unit's assets include more than 1,000 prospectively collected diagnostic samples from ovarian tumor studies, three biomarker-related pending U.S. patents, proprietary software and other intellectual property.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)
Acquirer
Aspira Women's Health
Primary Office
  • 1405 Research Boulevard
  • Suite 220
  • Rockville, MD 20850
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Correlogic Systems (Ovarian Cancer Diagnostics Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Correlogic Systems (Ovarian Cancer Diagnostics Business)‘s full profile, request access.

Request a free trial

Correlogic Systems (Ovarian Cancer Diagnostics Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Correlogic Systems (Ovarian Cancer Diagnostics Business)‘s full profile, request access.

Request a free trial